KvLQT2


Kv7.2 is a voltage- and Lipid-gated [ion channels|lipid-gated] potassium channel protein coded for by the gene KCNQ2.
Mutations in the KCNQ2 gene are dominant autosomally inherited causes of benign familial [neonatal epilepsy].

Function

The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and a related protein encoded by the KCNQ3 gene, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 1, also known as epilepsy, benign neonatal type 1. At least five transcript variants encoding five different isoforms have been found for this gene.

Ligands